Expert Opinion on Pharmacotherapy [ISSN 1465-6566]; [e-ISSN 1744-7666] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles and original papers on newly approved/near to launch compounds mainly of chemical/synthetic origin, providing expert opinion on the likely impact of these new agents on existing pharmacotherapy of specific diseases.
Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development.
Expert Opinion on Pharmacotherapy addresses the needs of research and development, regulatory and marketing decision makers in the pharmaceutical industry and decision makers in healthcare provision.
The Editors welcome:
- Reviews covering new drugs/drug classes for specific diseases, from development Phase III to those that have been available to pharmacopoeia for up to 5 years, and their potential impact on future treatment strategies.
- Drug Evaluations reviewing the clinical and pharmacological data on a particular drug.
- Original Research papers reporting the results of clinical investigations on agents that are in Phase III and IV clinical trials and pharmacologically based studies with a strong link to clinical practice.
Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.
Reach an international clinical and medical audience alongside other key option leaders in your field by publishing with Expert Opinion on Pharmacotherapy, part of the Expert Collection brand.
Authors can choose to publish gold open access in this journal.
Read the Instructions for Authors for information on how to submit your article. For any pre-submission enquiries, please contact the Commissioning Editor.
![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/110803/Subject-Sample-2021-Bioscience.jpg"})